Annual Short Term Debt
$624.40 M
+$577.46 M+1230.27%
December 31, 2023
Summary
- As of February 20, 2025, JAZZ annual short term debt is $624.40 million, with the most recent change of +$577.46 million (+1230.27%) on December 31, 2023.
- During the last 3 years, JAZZ annual short term debt has risen by +$363.62 million (+139.44%).
- JAZZ annual short term debt is now at all-time high.
Performance
JAZZ Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$50.10 M
-$572.84 M-91.96%
September 30, 2024
Summary
- As of February 20, 2025, JAZZ quarterly short term debt is $50.10 million, with the most recent change of -$572.84 million (-91.96%) on September 30, 2024.
- Over the past year, JAZZ quarterly short term debt has dropped by -$571.13 million (-91.93%).
- JAZZ quarterly short term debt is now -91.98% below its all-time high of $624.40 million, reached on December 31, 2023.
Performance
JAZZ Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
JAZZ Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1230.3% | -91.9% |
| 3 y3 years | +139.4% | -91.9% |
| 5 y5 years | +1770.2% | -91.9% |
JAZZ Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1235.3% | -92.0% | +9.2% |
| 5 y | 5-year | at high | +1254.0% | -92.0% | +9.5% |
| alltime | all time | at high | >+9999.0% | -92.0% | -100.0% |
Jazz Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $50.10 M(-92.0%) |
| Jun 2024 | - | $622.95 M(-0.1%) |
| Mar 2024 | - | $623.73 M(-0.1%) |
| Dec 2023 | $624.40 M(+1230.3%) | $624.40 M(+0.5%) |
| Sep 2023 | - | $621.23 M(+1194.7%) |
| Jun 2023 | - | $47.98 M(-0.5%) |
| Mar 2023 | - | $48.23 M(+2.8%) |
| Dec 2022 | $46.94 M(+0.4%) | $46.94 M(+2.3%) |
| Sep 2022 | - | $45.88 M(-1.3%) |
| Jun 2022 | - | $46.50 M(-1.4%) |
| Mar 2022 | - | $47.16 M(+0.8%) |
| Dec 2021 | $46.76 M(-82.1%) | $46.76 M(-2.7%) |
| Sep 2021 | - | $48.05 M(-82.2%) |
| Jun 2021 | - | $269.46 M(+2.6%) |
| Mar 2021 | - | $262.66 M(+0.7%) |
| Dec 2020 | $260.78 M(+465.5%) | $260.78 M(+1.4%) |
| Sep 2020 | - | $257.08 M(+457.0%) |
| Jun 2020 | - | $46.15 M(+0.9%) |
| Mar 2020 | - | $45.74 M(-0.8%) |
| Dec 2019 | $46.12 M(+38.1%) | $46.12 M(+2.3%) |
| Sep 2019 | - | $45.10 M(+7.1%) |
| Jun 2019 | - | $42.11 M(+0.1%) |
| Mar 2019 | - | $42.06 M(+26.0%) |
| Dec 2018 | $33.39 M(-17.8%) | $33.39 M(0.0%) |
| Sep 2018 | - | $33.39 M(0.0%) |
| Jun 2018 | - | $33.39 M(-26.0%) |
| Mar 2018 | - | $45.12 M(+11.1%) |
| Dec 2017 | $40.60 M(+12.5%) | $40.60 M(+12.5%) |
| Sep 2017 | - | $36.09 M(0.0%) |
| Jun 2017 | - | $36.09 M(-73.5%) |
| Mar 2017 | - | $136.09 M(+277.1%) |
| Dec 2016 | $36.09 M | $36.09 M(0.0%) |
| Sep 2016 | - | $36.09 M(-3.7%) |
| Jun 2016 | - | $37.50 M(-0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $37.59 M(+0.0%) |
| Dec 2015 | $37.59 M(+298.7%) | $37.59 M(-68.0%) |
| Sep 2015 | - | $117.59 M(+312.9%) |
| Jun 2015 | - | $28.48 M(+203.3%) |
| Mar 2015 | - | $9.39 M(-0.4%) |
| Dec 2014 | $9.43 M(+69.2%) | $9.43 M(-0.2%) |
| Sep 2014 | - | $9.44 M(-0.3%) |
| Jun 2014 | - | $9.47 M(-0.4%) |
| Mar 2014 | - | $9.51 M(+70.7%) |
| Dec 2013 | $5.57 M(-81.2%) | $5.57 M(0.0%) |
| Sep 2013 | - | $5.57 M(0.0%) |
| Jun 2013 | - | $5.57 M(-82.9%) |
| Mar 2013 | - | $32.66 M(+10.0%) |
| Dec 2012 | $29.69 M(+26.8%) | $29.69 M(+11.1%) |
| Sep 2012 | - | $26.72 M(+12.5%) |
| Jun 2012 | - | $23.75 M(>+9900.0%) |
| Sep 2011 | - | $0.00(-100.0%) |
| Jun 2011 | - | $36.69 M(+82.3%) |
| Mar 2011 | - | $20.13 M(-14.0%) |
| Dec 2010 | $23.41 M(-29.4%) | $23.41 M(+47.0%) |
| Jun 2010 | - | $15.93 M(-60.9%) |
| Mar 2010 | - | $40.73 M(+22.8%) |
| Dec 2009 | $33.16 M(-72.9%) | $33.16 M(+1005.3%) |
| Sep 2009 | - | $3.00 M(-79.5%) |
| Jun 2009 | - | $14.64 M(-88.2%) |
| Mar 2009 | - | $123.97 M(+1.3%) |
| Dec 2008 | $122.41 M(+3438.9%) | $122.41 M(+3649.1%) |
| Sep 2008 | - | $3.27 M(-46.5%) |
| Jun 2008 | - | $6.10 M(+91.8%) |
| Mar 2008 | - | $3.18 M(-8.1%) |
| Dec 2007 | $3.46 M(+57.9%) | $3.46 M(+33.2%) |
| Sep 2007 | - | $2.60 M(-17.1%) |
| Jun 2007 | - | $3.13 M(+1.0%) |
| Mar 2007 | - | $3.10 M(+41.7%) |
| Dec 2006 | $2.19 M | $2.19 M |
FAQ
- What is Jazz Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual short term debt year-on-year change?
- What is Jazz Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly short term debt year-on-year change?
What is Jazz Pharmaceuticals annual short term debt?
The current annual short term debt of JAZZ is $624.40 M
What is the all time high annual short term debt for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual short term debt is $624.40 M
What is Jazz Pharmaceuticals annual short term debt year-on-year change?
Over the past year, JAZZ annual short term debt has changed by +$577.46 M (+1230.27%)
What is Jazz Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of JAZZ is $50.10 M
What is the all time high quarterly short term debt for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly short term debt is $624.40 M
What is Jazz Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, JAZZ quarterly short term debt has changed by -$571.13 M (-91.93%)